EPA/DHA 1:1 | EPA/DHA 2:1 | EPA/DHA 1:2 | Soybean oil | Linseed oil | ||||
---|---|---|---|---|---|---|---|---|
Biomarkers | Mean ± SD | Mean ± SD | Mean ± SD | p | Mean ± SD | P | Mean ± SD | p |
CVD RISK MARKERS | ||||||||
Inflammation | ||||||||
CRP (μg/mL) | 147.0 ± 20.5 | 147.1 ± 22.4 | 140.1 ± 52.7 | 172.9 ± 38.2 | 142.9 ± 52.0 | |||
Thrombotic activity | ||||||||
PAI-1 (μg/mL) | 7.48 ± 1.3 | 8.75 ± 1.8 | 9.18 ± 1.3 | 6.45 ± 0.8 | c0.030 | 7.76 ± 1.1 | ||
Endothelial dysfunction | ||||||||
sVCAM (μg/mL) | 3.41 ± 0.7 | 3.01 ± 0.4 | 4.40 ± 1.3 | b0.046 | 3.36 ± 1.7 | 2.10 ± 0.4 | a0.001 | |
b0.001 | ||||||||
c0.003 | ||||||||
sICAM (ng/mL) | 0.59 ± 0.2 | 0.61 ± 0.2 | 0.53 ± 0.2 | 0.52 ± 0.1 | 0.59 ± 0.3 |